29 results
8-K
EX-10.1
LIXT
Lixte Biotechnology Holdings Inc
28 Nov 23
Departure of Directors or Certain Officers
5:21pm
Awards.
(f) Data Privacy. As a condition of receipt of any Award, each Participant explicitly and unambiguously consents to the collection, use … country may have different data privacy laws and protections. By accepting an Award, each Participant authorizes such recipients to receive, possess, use
8-K
EX-10.1
LIXT
Lixte Biotechnology Holdings Inc
20 Jul 23
Entry into a Material Definitive Agreement
11:45am
obligations relating to the privacy and security of IT Systems and Personal Data and to the protection of such IT Systems and Personal Data from unauthorized … , kickbacks, recordkeeping, documentation requirements, the hiring of employees (to the extent governed by Health Care Laws), quality, safety, privacy
8-K
EX-10.1
yyogbub7weeg2xp2da
15 Apr 22
LIXTE Biotechnology Announces $5.8 Million Registered Direct Offering Priced At-The-Market
12:00am
424B5
rby8q9 h76
14 Apr 22
Prospectus supplement for primary offering
6:15am
8-K
EX-10.1
emai4
20 Sep 21
Entry into a Material Definitive Agreement
5:21pm
8-K
EX-10.1
ohm67z9s emb1g
2 Mar 21
VI.Lixte Biotechnology Announces $4.19 Million Registered Direct Offering
4:55pm
424B5
mh9a3wc pinnk3n2p25
1 Mar 21
Prospectus supplement for primary offering
4:21pm
8-K
EX-10.1
6cf8grtv
22 Jan 21
Entry into a Material Definitive Agreement
2:00pm
424B4
h12ym
27 Nov 20
Prospectus supplement with pricing info
5:25pm
8-K
EX-1.1
wgcx7eua
27 Nov 20
Lixte Biotechnology Holdings, Inc. Announces Pricing of $5,700,000 Public Offering; Uplisting to Nasdaq Capital Market and Reverse Stock Split
4:43pm